Filter News

OncLive: Physician and patient perspectives on diagnosis and treatment in essential thrombocythemia

April 14, 2020

OncLive teamed up with “CURE Talks Cancer” podcast, and interviewed Dr. Ruben Mesa, director of the Mays Cancer Center, and his patient who has been living with essential thrombocythemia for years, to discuss her treatment course and gain clinical insi …


WQAD: Your Health: Something better than Naloxone

April 14, 2020

Interview of UT Health San Antonio pharmacology professor Charles France, Ph.D., is carried by WQAD-TV, Moline, IL., on the topic of Your Health: Something better than Naloxone. Read and watch the story.


CURE: Patient-Doctor duo: The basics of myeloproliferative neoplasms

April 14, 2020

Dr. Ruben Mesa, Mays Cancer Center director, explains myeloproliferative neoplasms from both, a doctor’s and a patient’s point of view on CureToday.com.


Texas Standard: Ask a doctor: What’s the criteria for ‘release’ from self-quarantine, and other questions answered

April 14, 2020

Dr. Fred Campbell, General and Hospital Medicine, answers listeners’ questions on the statewide public radio program Texas Standard about their health during the COVID-19 pandemic.


Dr. Lee

Autism’s impact on individuals and families

April 13, 2020

It’s likely that someone you know has autism. April is Autism Awareness Month and recognition of this disorder is very important because it impacts one out of 68 people and their families. Autism is a developmental behaviorally-defined syndrome. Childr …


Close up Bag of blood on blur background.

A breakthrough in the way blood is stored

April 13, 2020

UT Health San Antonio played a major research role in the FDA’s recent approval of a new process that nearly triples the five-day shelf life of blood platelets, commonly used for treating trauma patients.


Close up Bag of blood on blur background.

FDA approves tripling platelets’ shelf life based on UT Health San Antonio research

April 13, 2020

Media contact: Susan Anasagasti, anasagasti@uthscsa.edu, (305) 903-8829 SAN ANTONIO (April 13, 2020) — UT Health San Antonio played a major research role in the FDA’s recent approval of a new process that nearly triples the five-day shelf life of blood …


OncLive: Dr. Mesa on unanswered questions regarding JAK inhibitors in myelofibrosis

April 13, 2020

Dr. Ruben Mesa discusses the treatment of patients with myelofibrosis.


San Antonio Express-News: San Antonio patients undergo cancer treatment during COVID-19

April 13, 2020

Dr. Ruben Mesa explained the many precautions taken to help prevent sickness among cancer patients during the COVID-19 outbreak.


embracing caregiver

Caring for the caregiver during COVID-19

April 13, 2020

Parents, grocery store workers, teachers and everyone in between have had to adjust to a new normal during the current COVID-19 pandemic. No one is exempt from feeling the effects of social distancing and that includes caregivers. Social distancing, wh …


Filter news